Thursday, 26 April 2018 - 14:39
  • it
  • de
  • en
  • fr


GSK seeks to protect Advair through GBP1.2bn acquisition of Vectura

The British newspaper The Telegraph has reported today that the pharma giant GSK is about to offer GBP1.2bn for UK-based Vectura. The reported offer corresponds to GBP1.75 per share, that is a 53% premium over yesterday’s closing price. A takeover…

GSK celebrates non-approval of Hikma-developed generic Advair

GlaxoSmithKline scored another victory as FDA this week rejected to approve the generic of blockbuster Advair Diskus, developed by generic manufacturer Hikma. Britain-based Hikma Pharmaceuticals is seeking the same multibillion-pound sales that the asthma drug (fluticasone propionate and salmeterol) developed…